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linear energy transfer (LET), dose, and dose rate. In general, 
high LET radiations such as neutrons and α‑particles produce 
far more severe biological effects than γ‑rays and X‑rays, which 
are low‑LET radiations. Epidemiological studies identified 
radiation‑induced cancer risks at doses above 50 mSv based on 
the cancer incidence observed among the A‑bomb survivors.[1] 
Although radiation can cause potential health effects, radiation 
is still the preferred treatment modality for a majority of  human 
cancers.[2,3] Thus, ionizing radiation appears to be a double‑edged 
sword, which can cause cancer on the one side and control cancer 
progression and spreading on the other.
Occupational or accidental radiological or nuclear exposure can 
cause serious health effects. In addition, radiological or nuclear 
terrorism constitutes a potential threat to several nations, where 
several hundreds and thousands of  people may potentially get 
exposed to radiation. We learn from the nuclear disasters of  
Chernobyl and Fukushima Daiichi that the first responders to 
these radiation emergencies sustained high levels of  radiation 
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Humans are exposed to ionizing radiation not only through background radiation but also through the ubiquitous presence of devices and 
sources that generate radiation. With the expanded use of radiation in day‑to‑day life, the chances of accidents or misuse only increase. Therefore, 
a thorough understanding of the dynamic effects of radiation exposure on biological entities is necessary. The biological effects of radiation 
exposure on human cells depend on much variability such as level of exposure, dose rate, and the physiological state of the cells. During potential 
scenarios of a large‑scale radiological event which results in mass casualties, dose estimates are essential to assign medical attention according 
to individual needs. Many attempts have been made to identify biomarkers which can be used for high throughput biodosimetry screening. In 
this study, we compare the results of different biodosimetry methods on the same irradiated cells to assess the suitability of current biomarkers 
and push forward the idea of employing a multiparametric approach to achieve an accurate dose and risk estimation.
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Introduction
Human beings are being exposed to ionizing radiation in every 
walk of  life because of  its diverse use from medical diagnostics to 
industrial applications. In addition, human exposure to radiation 
from cosmic rays and naturally occurring radon has become 
unavoidable. Three different models have been proposed to 
describe the biological effects of  ionizing radiation: (i) Linear 
threshold, (ii) linear no‑threshold, and (iii) hormesis. Among 
them, the linear no‑threshold model assumes that radiation is 
harmful irrespective of  the dose and that there is no threshold 
for radiation‑induced probabilistic or stochastic effects. 
Therefore, stochastic effects such as gene mutations and cancer 
incidence are of  great concern to humans. Biological effects 
of  ionizing radiation depend on radiation quality defined by 
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exposures. These incidences clearly illustrate a critical need for 
suitable biomarkers for personalized radiation dose assessment, 
which can be useful not only for appropriate medical/clinical 
management but also for predicting delayed stochastic (no 
threshold) effects such as genomic instability and cancer.
In the past several decades, various new biodosimetry assays have 
been developed, and the existing ones have undergone technical 
improvements to better estimate absorbed radiation dose. In 
the absence of  physical dosimeters, biomarkers or biological 
dosimeters can be of  immense help in estimating the absorbed 
radiation dose in certain accidental situations that involve 
nonnuclear workers and the general public. Further, biodosimeters 
can help in risk stratification of  the exposed people and assist 
in appropriate medical management of  individuals who received 
high doses of  radiation exposure. In case of  a radiological or a 
nuclear mass‑casualty event, several hundreds and thousands of  
people may get exposed. Such situation(s) may require technical 
improvements in existing biodosimetry assays to meet the 
requirements by radiological triage. In addition, biodosimetry 
can be helpful in guiding medical treatment of  radiation accident 
victim if  assessment is made in a timely manner.
Exposure to ionizing radiation results in a variety of  biological 
effects that depend on physical nature, exposure duration, dose, 
and dose rate. Although biodosimeters can help in absorbed 
radiation dose estimation, there is still a big gap in our knowledge 
with regard to prediction of  health risks from estimated radiation 
dose. Therefore, a thorough understanding of  biological 
effects may help in predicting the short‑ and long‑term effects 
of  radiation exposure. Different biodosimetry assays that are 
currently used are briefly described below.
Dicentric Chromosome Assay
This method is considered as the “gold standard” for radiation 
dose assessment.[4,5] The method was first used by Bender 
and Gooch as a dosimeter to assess the human exposure to 
radiation.[6] Dicentric analysis is widely used for radiation dose 
estimation in individuals following accidental and nuclear 
exposures. Conventionally, G‑banding and/or Giemsa staining 
was used in the analysis of  dicentrics in lymphocytes following 
irradiation.[7‑12] The dicentric chromosome assay (DCA) is labor 
intensive and time consuming, requiring 72–96 h for dose 
estimation. Some of  the recent developments of  this assay 
include automated image capturing as well as dicentric scoring 
using Metafer and telescoring of  digital images of  metaphase 
spreads by a large number of  skilled and experienced scorers. 
Recent studies have demonstrated an increased sensitivity of  
dicentric chromosome detection and scoring by employing 
fluorescence in situ hybridization (FISH) using centromere‑ and 
telomere‑specific peptide nucleic acid (PNA) probes. FISH‑based 
DCA has not only increased the sensitivity but also considerably 
reduced the analysis time. We have successfully employed 
the PNA‑FISH technique for the detection of  chromosome 
aberrations in several of  our earlier studies.[13‑15] An example of  
a metaphase spread stained for telomeres and centromeres using 
PNA probes is shown in Figure 1a.
Using the PNA‑FISH technique, we have constructed a 
calibration curve in our laboratory using the peripheral blood 
lymphocytes of  three healthy human donors following ex vivo 
irradiation with a range of  doses (0, 0.25, 0.5, 1.0, 2.0, 3.0, and 
4.0 Gy) of  γ rays at a dose rate of  0.85 Gy/min. The data are 
shown in Figure 1c. In addition to dicentric chromosomes, 
frequency of  chromosome ends without telomeres was also 
estimated to determine the possibility of  using this feature as 
a potential biomarker for radiation exposure [Figure 2a and b]. 
Although initial studies are promising, further experiments are 
required for verification and validation.
Cytokinesis‑block Micronucleus Assay
Cytokinesis‑block micronucleus (CBMN) has gained considerable 
importance recently as one of  the reliable indicators of  radiation 
exposure although micronuclei formation is not entirely specific 
to radiation alone. This assay detects micronuclei [Figure 1b] 
resulting from either whole chromosomes or chromosome 
fragments that are excluded from mitotic spindle during cell 
division. Originally, the CBMN assay was developed by Fenech 
and Morley[16,17] using human peripheral blood lymphocytes. 
In the subsequent years, the CBMN technique incorporated 
FISH with centromeric and telomeric probes that enabled 
the detection of  either whole chromosome or chromosome 
fragments in micronuclei. A recent study utilized the multicolor 
FISH technique to identify the chromosomes involved in 
Figure 1: Cytogenetic damage in human lymphocytes following 
exposure to γ‑rays analyzed by chromosome and micronuclei 
analyses.  (a) Peptide nucleic acid‑fluorescence in situ hybridization 
was used to detect dicentric chromosomes. Cy3‑telomere (red) and 
FITC‑centromere (green) peptide nucleic acid probes were used 
along with counterstain DAPI (blue). Metaphase spread shows a 
dicentric chromosome. (b) Acridine orange stained cytokinesis‑blocked 
binucleated human lymphocytes. Arrow points to a micronucleus 
present in this cell. (c) Frequencies of dicentrics (blue rectangles) and 
micronuclei (red rectangles) following gamma irradiation with different 
doses  (0,  0.25,  0.5,  1.0,  2.0,  3.0,  and 4 Gy).  The data were  fitted 
with polynomial function, and the following equations were obtained: 
Dicentrics: y = 0.0516x2 + 0.0291x − 0.0023 (R² =0.999); Micronuclei: 
y = 0.0249x2 + 0.005x + 0.0157 (R2 = 0.9934)
a
b c
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micronuclei formation after radiation exposure.[18] Recently, a 
new high‑throughput and miniaturized CBMN method was also 
established for rapid processing a large number of  samples (in 
about 3 days), a critical requirement for radiological triage.[19,20] 
Since the CBMN assay, unlike the DCA, can be easily performed 
and analyzed without an extensive cytogenetic expertise, many 
laboratories routinely use the CBMN assay for dose estimation. 
Both CBMN and DCA can be used in a complementary fashion 
for dose estimation. Calibration curves constructed from the data 
of  both assays performed in the lymphocytes of  three human 
donors are given in Figure 1c.
Chromosome Translocation Assay 
by Multicolor Fluorescence In situ 
Hybridization
Multicolor FISH is very useful technique for genome‑wide 
analysis of  numerical and structural changes in humans. Using 
this technique, ionizing radiation‑induced simple and complex 
chromosomal exchanges (translocations and inversions) can 
be easily and reliably detected [Figure 3a and b]. These stable 
chromosomal exchange events can be effectively used for 
retrospective biodosimetry because of  their persistence for 
prolonged periods of  time after radiation exposure. Using 
this technique, simple and complex chromosome exchanges 
were detected several years after exposure to plutonium in the 
lymphocytes of  a few nuclear workers of  Mayak, Russia.[21] The 
use of  translocations in retrospective biodosimetry has been 
amply demonstrated in several studies. The overall assay time for 
translocation analysis can range from 10 to 14 days depending 
on the quality of  metaphases and hybridization.
γ‑H2AX Assay
Histone H2AX, a variant of  histone H2A, is rapidly phosphorylated 
at serine 139 by exposure to DNA double‑strand break (DSB) 
causing agents including ionizing radiation.[22] Phosphorylated 
H2AX (γ‑H2AX) has been shown to accumulate at the DSB 
sites [Figure 2c] and is considered as a surrogate marker for 
DSBs.[23] Several studies have demonstrated the usefulness 
of  γ‑H2AX in dose estimation through DSB detection.[24‑27] 
This assay, unlike DCA and CBMN, obviates the need for 
lymphocyte stimulation for 48–72 h making it a rapid assay for 
dose estimation in radiological triage.[28] However, fast kinetics 
of  γ‑H2AX foci formation [Figure 2d] and disappearance within 
a narrow window of  6–8 h makes it somewhat unreliable for 
precise dose estimation. Nevertheless, this assay can be definitely 
useful more as a biological indicator of  radiation exposure rather 
than a radiation biodosimeter.
Gene Expression Profiling
It has become evident that studying a single gene response is 
no longer conclusive.[29] Array‑based gene expression studies 
have yielded valuable information on ionizing radiation‑specific 
genes. Identification of  signaling pathways associated with 
radiation‑specific genes as well as posttranslational modification 
of  proteins encoded by these genes have given great insights for 
understanding the diverse biological effects induced by low and 
high doses of  ionizing radiation with differing LET in diverse 
mammalian model systems including humans. Available data 
on tissue‑specific expression of  radiation‑responsive genes can 
help in predicting the organ/tissue‑specific effects. Recently, 
Lu et al.[30] identified changes in 29 genes which are involved in 
cell cycle as a biomarker for predicting low doses of  radiation 
exposure. This method can be effectively employed to predict 
the postexposure impact in terms of  disease outcome. One 
of  the first studies to use microarray analysis to investigate 
the radiation response revealed that about 1344 genes were 
Figure 3: Multicolor  fluorescence in situ hybridization was used to 
visualize the stable chromosome translocations in human lymphocytes 
after exposure to gamma radiation. (a) A reciprocal translocation 
between chromosomes 13 and 9 [t(13,9)] is shown. (b) The same 
metaphase as in A observed under ultraviolet filter
a b
Figure 2: Chromosome and DNA breaks induced by radiation in human 
lymphocytes. (a) Chromosome ends with undetectable telomeres: 
Partial metaphase spread showing chromosomes and fragments 
with undetectable telomeres. Arrows point to the chromosome ends 
without any telomere signal. (b) Analysis of fragments and chromosome 
ends without telomere signals showed a dose‑dependent response 
as well as heterogeneity among the different samples studied. 
(c and d) Induction and kinetics of γH2AX foci following exposure 
to gamma radiation as a measure of DNA double‑strand breaks in 
human lymphocytes. (c) Immunofluorescence staining of nuclei with 
anti‑γH2AX antibodies (Green) and DAPI as a counterstain (Blue). (d) At 
2 h postirradiation, the γH2AX foci were induced in a dose‑dependent 
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differentially expressed in a myeloid cancer cell line following 
2 Gy irradiation at 4 h.[31]
We used Illumina microarray chip to determine gene expression 
changes following gamma‑ray exposure in human lymphocytes. 
Analysis compared the expression profile between the 
nonirradiated and the irradiated cells from the same donor. 
Expression profile at two time points (2 h and 24 h) was analyzed 
in the study. Experimental data shown in Figure 4a represent the 
principle component analysis based clustering and subclustering 
of  the various data points including donors and postirradiation 
time points. The data showed clear differences in the response 
of  genes based on postirradiation time as well as individual 
radiosensitivity. However, from biomarker point of  view, 
upregulated genes are preferred than the downregulated genes.
To determine whether or not the differentially regulated genes 
are interconnected within a larger “signaling network,” the 
selected genes were used to construct intracellular signaling 
networks based on their expression pattern. During the initial 
step, we searched and analyzed direct interactions between the 
differentially regulated genes using the information extracted 
from the published experimental literature and from the entire 
National Center for Biotechnology Information – PubMed 
database. This set of  interactions defined the cellular potential 
for the assembly of  protein complexes, signaling, and effector 
pathways as well. By positioning the expression data onto known 
validated physical interactions, all possible associations between 
the regulated genes from our microarray expression data were 
restricted to those that are considered to be physically possible 
in the cell. This approach generated condition‑specific functional 
“signature networks,” which contained sets of  functional 
pathways organized into a meta‑network. Several well‑known 
key components of  DNA damage response are represented in 
the network, including DNA metabolism, DNA repair, and cell 
cycle regulation. Genes that were not shown to be associated 
with radiation‑response pathways earlier were also observed 
such as immune and inflammation mediators responses including 
cytokine signaling. Recently, there is growing evidence regarding 
the role of  immune/inflammatory response following radiation 
exposure which can contribute to bystander effects. Furthermore, 
the knowledge of  radiation‑induced inflammatory and immune 
responses would be beneficial in titrating radiation‑based 
therapeutics. This suggests a broader genetic participation in 
response to radiation exposure than previously thought and 
highly interacting pathways previously thought to be disjoint.
Gene clusters from the pathways such as immune response, 
apoptosis and inflammation, and DNA damage response are 
clearly activated after irradiation [Figure 4b]. We have identified 
around 70 genes, which are differentially expressed in all the 
donors studied to the dose range 0.1–1.0 Gy compared to 
the basal levels in control cells (Data not shown). A similar 
number of  genes were identified at 24 h postradiation exposure. 
Currently, we are validating these genes in our samples. Although 
gene expression studies have yielded valuable information, 
interindividual variation in transcription profile is too extensive 
for reliable dose estimation. In fact, no fruitful attempt has yet 
been made to estimate the radiation dose in exposed individuals 
using gene expression analysis. However, gene expression assay is 
an expensive and time‑consuming technology; specific circulating 




and gene network of radiation‑induced changes. The gene network was constructed using Pathway Studio (Ariadne Genomics MD, USA) on the 
basis of biological function of the differentially expressed genes by microarrays and the knowledge obtained in the literature. Red color denotes 
upregulated genes. Blue lines indicate direct regulation between genes based on literature evidence
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specific proteins or microRNAs may be more functional as 
potential emerging biomarkers of  radiation exposure. Recently, 
attempts have been made to analyze gene expression profiles of  
cancer patients undergoing radiotherapy. More robust studies 
are needed to verify the suitability of  gene expression profiling 
assay for radiation dose estimation.
Perspective
A multiparametric approach involving different bioassays 
may have the potential for accurate exposure dose prediction. 
However, variations exist in radiation dose estimated by 
different biodosimetry assays – both current and emerging 
methods. Interindividual variation seems to be an important 
confounding factor in most of  the assays. This study is an 
attempt to integrate several assays used in biodosimetry for the 
same sample to determine the best combination of  biomarkers 
that could be used following radiation exposures. This is a study 
in progress, and we are consolidating the data and refining 
some approaches that were used in this study. In addition to 
the established methods, emerging proteomic approach might 
prove to be a promising tool for the discovery of  new potential 
biomarkers of  radiation exposure. These markers, once validated, 
can be used in biodosimetry in case of  a radiological incident/
accident. Biomarkers will complement other modes of  radiation 
dosimetry. Apart from estimating the dose of  incident radiation, 
biodosimetry may help in predicting health consequences of  
radiation exposure in a population. Biodosimetry will facilitate 
stratification of  individuals who need immediate attention 
and potential medical countermeasures required to mitigate 
some of  the radiation‑associated injuries. In certain cases, it 
is possible to predict long‑term risks associated with radiation 
exposures. Indeed, current refinement in the methodologies 
used, identification of  new robust markers, and collaborations 
among the individual laboratories across the globe will greatly 
improve radiation emergency preparedness in case of  unexpected 
radiological or nuclear mass‑casualty events.
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